Supernus Pharmaceuticals, Inc. (SUPN)
Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention.
Beschreibung
Börse
Branche
Land
Aktiv:keine
| Unternehmen | Rating | |||||
|---|---|---|---|---|---|---|
| Daten werden geladen… | ||||||
Gespeicherte Screens und vollständige Daten: mit dem Abo
Abonniere, um Filter zu speichern und alle Spalten und Ratings freizuschalten.
Abonnieren - 24,90 €/Monat